$YJGJ
YIJIA GROUP CORP.

2023 Q3 Form 10-Q Financial Statement

#000168316823006437 Filed on September 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $24.25K
YoY Change 88.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $24.25K
YoY Change 88.46%
Operating Profit -$24.25K
YoY Change -1236.22%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$24.25K
YoY Change -1238.36%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$24.25K
YoY Change -1236.22%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 5.871M shares
Diluted Shares Outstanding 5.871M shares

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.46K
YoY Change 33.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.46K
Total Long-Term Liabilities
Total Liabilities $83.46K
YoY Change 33.03%
SHAREHOLDERS EQUITY
Retained Earnings -$148.2K
YoY Change 51.88%
Common Stock $5.871K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$83.46K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change -100.0%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$24.25K
YoY Change -1236.22%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$26.15K
YoY Change -485.59%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $17.42K
YoY Change
NET CHANGE
Cash From Operating Activities -$26.15K
Cash From Investing Activities
Cash From Financing Activities $17.42K
Net Change In Cash -$8.728K
YoY Change -228.71%
FREE CASH FLOW
Cash From Operating Activities -$26.15K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001699709
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 us-gaap Assets
Assets
usd
CY2023Q2 YJGJ Amount Due To Director Current
AmountDueToDirectorCurrent
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-07-31
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
333-218733
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
Yijia Group Corp.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2583762
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
30 N Gould St
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 22545
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Sheridan
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
WY
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
82801
CY2023Q3 dei City Area Code
CityAreaCode
310
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
266-3738
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5871250 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8728 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
8728 usd
CY2023Q2 us-gaap Assets
Assets
8728 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
49943 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
51843 usd
CY2023Q3 YJGJ Amount Due To Related Party Current
AmountDueToRelatedPartyCurrent
16237 usd
CY2023Q2 YJGJ Amount Due To Related Party Current
AmountDueToRelatedPartyCurrent
16100 usd
CY2023Q3 YJGJ Amount Due To Director Current
AmountDueToDirectorCurrent
17282 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
83462 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
67943 usd
CY2023Q3 us-gaap Liabilities
Liabilities
83462 usd
CY2023Q2 us-gaap Liabilities
Liabilities
67943 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5871 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5871 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58824 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58824 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148157 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123910 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-83462 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-59215 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8728 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
15000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24247 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12866 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
24247 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
12866 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24247 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2134 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24247 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2134 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24247 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2134 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5871250 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5871250 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5871250 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5871250 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-59215 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24247 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-83462 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34988 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2134 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-32854 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24247 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2134 usd
CY2023Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1900 usd
CY2022Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4647 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26147 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6781 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
137 usd
CY2022Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q3 YJGJ Proceed From Director
ProceedFromDirector
17282 usd
CY2022Q3 YJGJ Proceed From Director
ProceedFromDirector
0 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17419 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8728 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6781 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8728 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23103 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29884 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3880 usd
CY2023Q3 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_800_eus-gaap--BasisOfAccounting_ziEKFZRq1xKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1 – <i><span id="xdx_82D_zXWh67lUi867">BASIS OF PRESENTATION</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed financial statements have been prepared by management in accordance with both accounting principles generally accepted in the United States (“GAAP”), and the instructions to Form –Q and Rule 10-01 of Regulation S-X. Certain information and note disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, the condensed balance sheet as of April 30, 2023 which has been derived from audited financial statements and these unaudited condensed financial statements reflect all normal and considered necessary to state fairly the results for the periods presented. The results for the period ended July 31, 2023 are not necessarily indicative of the results to be expected for the entire fiscal year ending April 30, 2024 or for any future period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These unaudited condensed financial statements and notes thereto should be read in conjunction with the Management’s Discussion and the audited financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended April 30, 2023, <span style="background-color: white">filed with the SEC on May 15, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2023Q3 YJGJ Working Capital
WorkingCapital
-83462 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148157 usd
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_z7iy3tFQybO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31113 usd
CY2023Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
5092 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
148157 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
148157 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
123910 usd
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31113 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26021 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31113 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26021 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd

Files In Submission

Name View Source Status
0001683168-23-006437-index-headers.html Edgar Link pending
0001683168-23-006437-index.html Edgar Link pending
0001683168-23-006437.txt Edgar Link pending
0001683168-23-006437-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yijia_ex3101.htm Edgar Link pending
yijia_ex3201.htm Edgar Link pending
yijia_i10q-073123.htm Edgar Link pending
yjgj-20230731.xsd Edgar Link pending
yjgj-20230731_def.xml Edgar Link unprocessable
yjgj-20230731_cal.xml Edgar Link unprocessable
yjgj-20230731_pre.xml Edgar Link unprocessable
yjgj-20230731_lab.xml Edgar Link unprocessable
yijia_i10q-073123_htm.xml Edgar Link completed